Search research articles
Contact Us
Filters
Showing results (31-40 of 117) with videos related to
Page
of 12
Sort By:
Therapeutic Advances in Medical Oncology
|
August 4, 2022
Cabozantinib combination therapy for the treatment of solid tumors: a systematic review
Daniel Castellano, Andrea B Apolo, Camillo Porta, et al.
Cancer
|
August 9, 2025
Top advances of the year: Bladder cancer
Andrea B Apolo, Saad Atiq, Andre R Kydd, et al.
Journal for Immunotherapy of Cancer
|
December 20, 2018
Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report
Cecilia Monge, Hoyoung Maeng, Alessandra Brofferio, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 24, 2022
Evolving Role of Adjuvant Systemic Therapy for Kidney and Urothelial Cancers
Andrea B Apolo, Pavlos Msaouel, Scot Niglio, et al.
Thyroid : Official Journal of the American Thyroid Association
|
April 15, 2014
Cabozantinib-induced thyroid dysfunction: a review of two ongoing trials for metastatic bladder cancer and sarcoma
Sahzene Yavuz, Andrea B Apolo, Shivaani Kummar, et al.
Urologic Oncology
|
September 17, 2024
Adjuvant immunotherapy in high-risk muscle invasive urothelial carcinoma: A systematic review and meta-analysis of randomized clinical trials
Laura Oscar-Thompson, Carlos Riveros, Guru Sonpavde, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 3, 2022
Nivolumab plus ipilimumab plus cabozantinib triplet combination for patients with previously untreated advanced renal cell carcinoma: Results from a discontinued arm of the phase III CheckMate 9ER trial
Andrea B Apolo, Thomas Powles, Bernard Escudier, et al.
Clinical Case Reports
|
January 31, 2020
Neurotoxicities associated with checkpoint inhibitors: Two case reports and a review of the literature
Lisa M Cordes, Nicole N Davarpanah, Lauren B Reoma, et al.
Radiology. Imaging Cancer
|
April 20, 2021
CT Evaluation of Lymph Nodes That Merge or Split during the Course of a Clinical Trial: Limitations of RECIST 1.1
Ahmad Shafiei, Mohammadhadi Bagheri, Faraz Farhadi, et al.
Current Opinion in Oncology
|
April 4, 2024
Organ preservation in muscle-invasive urothelial bladder cancer
Scot A Niglio, Juhi M Purswani, Peter B Schiff, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 117) with videos related to
Sort By:
Page
of 12
Therapeutic Advances in Medical Oncology
|
August 4, 2022
Cabozantinib combination therapy for the treatment of solid tumors: a systematic review
Daniel Castellano, Andrea B Apolo, Camillo Porta, et al.
Cancer
|
August 9, 2025
Top advances of the year: Bladder cancer
Andrea B Apolo, Saad Atiq, Andre R Kydd, et al.
Journal for Immunotherapy of Cancer
|
December 20, 2018
Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report
Cecilia Monge, Hoyoung Maeng, Alessandra Brofferio, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 24, 2022
Evolving Role of Adjuvant Systemic Therapy for Kidney and Urothelial Cancers
Andrea B Apolo, Pavlos Msaouel, Scot Niglio, et al.
Thyroid : Official Journal of the American Thyroid Association
|
April 15, 2014
Cabozantinib-induced thyroid dysfunction: a review of two ongoing trials for metastatic bladder cancer and sarcoma
Sahzene Yavuz, Andrea B Apolo, Shivaani Kummar, et al.
Urologic Oncology
|
September 17, 2024
Adjuvant immunotherapy in high-risk muscle invasive urothelial carcinoma: A systematic review and meta-analysis of randomized clinical trials
Laura Oscar-Thompson, Carlos Riveros, Guru Sonpavde, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 3, 2022
Nivolumab plus ipilimumab plus cabozantinib triplet combination for patients with previously untreated advanced renal cell carcinoma: Results from a discontinued arm of the phase III CheckMate 9ER trial
Andrea B Apolo, Thomas Powles, Bernard Escudier, et al.
Clinical Case Reports
|
January 31, 2020
Neurotoxicities associated with checkpoint inhibitors: Two case reports and a review of the literature
Lisa M Cordes, Nicole N Davarpanah, Lauren B Reoma, et al.
Radiology. Imaging Cancer
|
April 20, 2021
CT Evaluation of Lymph Nodes That Merge or Split during the Course of a Clinical Trial: Limitations of RECIST 1.1
Ahmad Shafiei, Mohammadhadi Bagheri, Faraz Farhadi, et al.
Current Opinion in Oncology
|
April 4, 2024
Organ preservation in muscle-invasive urothelial bladder cancer
Scot A Niglio, Juhi M Purswani, Peter B Schiff, et al.
Page
of 12